FDA Issues Warning Letters to Companies Selling CBD Products for Pain Relief

Last week the FDA issued warning letters to Honest Globe, Inc. (March 15, 2021) and Biolyte Laboratories, LLC (March 18, 2021) for selling products containing cannabidiol (CBD) in violation of the Federal Food, Drug and Cosmetic Act (the “Act”). A principle issue addressed by FDA in the letters is the sale of the CBD containing... Continue Reading